Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Haploidentical Hematopoietic Stem Cell Transplantation Followed by ‘Post-Cyclophosphamide’: The Future of Allogeneic Stem Cell Transplant

1 Jan 2020

Abstract excerpt

Allogeneic hematopoietic cell transplant (Allo-HCT) is a potentially curative therapy for many malignant and nonmalignant hematological diseases. However, a suitable human leukocyte antigens (HLAs)-matched donor may not be available when the patient is in urgent need of a stem cell transplant. This challenge has been ameliorated to a large extent by the introduction of haploidentical donors. This type of donor...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Lymphoblastic Leukemia research
Share to Hematopoietic Stem Cell Transplantation
Share to Immune Cell Function and Interaction

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34595443
DOI: 10.2991/chi.d.200405.001

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Haploidentical Hematopoietic Stem Cell Transplantation Followed by ‘Post-Cyclophosphamide’: The Future of Allogeneic Stem Cell TransplantPMID 34595443Read ↗

Haploidentical hematopoietic transplantation: current status and future perspectivesSemantic proximity Read ↗

The history of haploidentical stem cell transplantation: a trip from the bench to the bedsideSemantic proximity Read ↗

Haploidentical hematopoietic stem cell transplantation in children and adolescents with acquired severe aplastic anemiaSemantic proximity Read ↗

One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donorsSemantic proximity Read ↗

Haploidentical hematopoietic transplantation for the cure of leukemia: from its biology to clinical translationSemantic proximity Read ↗

The impact of donor-specific anti-human leukocyte antigen antibodies in salvage haploidentical hematopoietic cell transplantation with posttransplant cyclophosphamide in patients with nonmalignant disorders.Semantic proximity Read ↗

A survey on unmanipulated haploidentical hematopoietic stem cell transplantation in adults with acute leukemia.Semantic proximity Read ↗

Selecting the Best Donor for Haploidentical Transplant: Impact of HLA, Killer Cell Immunoglobulin-Like Receptor Genotyping, and Other Clinical VariablesSemantic proximity Read ↗

Haploidentical transplantation for hematologic malignancies: where do we stand?Semantic proximity Read ↗

HLA Matching in Pediatric Stem Cell TransplantationSemantic proximity Read ↗

Hematopoietic stem cell transplants from unrelated donorsSemantic proximity Read ↗

Haplobanking induced pluripotent stem cells for clinical useSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.